# TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

> **NCT00130468** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 150 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Hyalgan (sodium hyaluronate)

## Key facts

- **NCT ID:** NCT00130468
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 150 (—)
- **Last updated:** 2008-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130468, "TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00130468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*